Skip to main content

Table 3 Sensitivity analysis for correlation of Ang-2 expression and survival of NSCLC patients

From: Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis

Study omitted Resulting HR (95 % CI)
None 1.93 (1.47–2.52)
Andersen 2011 1.95 (1.41–2.69)
Park 2007 1.92 (1.40–2.62)
Massabeau 2008 1.97 (1.47–2.63)
Coelho 2014 1.90 (1.40–2.57)
Daly 2014 1.91 (1.44–2.53)